Jivora Toxiplex Basic (Aflatoxin B1, Deoxynivalenol, Fumonisin (B1 & B2), Ochratoxin A, and Zearalenone)™

Jivora Toxiplex Basic (Aflatoxin B1, Deoxynivalenol, Fumonisin (B1 & B2), Ochratoxin A, and Zearalenone)™

The Jivora Toxiplex Basic Home Blood Collection Kit provides a streamlined home collection system designed to gather blood specimens for an overarching screening of the body’s immune standing regarding Toxoplasma gondii.

Who It’s For

This screen is tailored for cat owners, individuals who consume raw or undercooked meats, gardeners, or pregnant individuals seeking to verify their historical exposure baselines to Toxoplasma. It serves as an accessible tool for general baseline wellness documentation.

What It Measures

The lab evaluation looks for antibody combinations or cellular indicators associated with exposure to Toxoplasma gondii, establishing whether an individual lacks exposure history, has an active response, or possesses long-term immune protection.

How it works (3 steps):

• Order
• Collect at home & return ship 
• Get results and review next steps

More About Your Jivora Toxiplex Basic (Aflatoxin B1, Deoxynivalenol, Fumonisin (B1 & B2), Ochratoxin A, and Zearalenone)™

Convenient Access to Wellness Insights

You can order your testing kit directly through Jivora Health, an authorized ArminLabs partner. Our streamlined online process respects your privacy and security, allowing you to take a proactive role in monitoring your immune health without the need for a prior office visit.

Simple, Needle-Free Collection at Home

Each kit features the FDA-cleared Tasso+ device, designed for easy and virtually painless blood collection from the upper arm. This innovative technology allows you to collect a high-quality sample without traditional needles. If you prefer, a standard clinical blood draw option is also available. Both methods are validated for sample stability and laboratory accuracy.

Informational Results for Better Conversations

Your report provides a detailed look at how your immune system reacts to specific tick-borne antigens. These findings are educational in nature and intended to help you have more informed discussions with your healthcare provider. Please note that these results are not a medical diagnosis and should not be used as a standalone basis for a treatment plan.

Medications and Testing

While most common medications do not impact the results, certain intensive therapies - such as strong immunosuppressants, chemotherapy, or interferon-gamma therapy - may affect your immune system’s natural reactivity. We recommend consulting your clinician before sample collection if you are currently undergoing these treatments.

Fast, Secure, and Supported

Once your sample is received by the laboratory, your secure digital report is typically available within 7 to 10 business days. To help you navigate your findings, Jivora Health provides access to a complimentary educational review to explain the data markers in your report.

Comprehensive Immune Screening

Traditional screenings often focus on a single strain of Borrelia. The ArminLabs approach provides a broader perspective by screening for reactivity to Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. By including persistent-form (round-body) antigens, this test offers a more comprehensive view of your immune profile, reducing the limitations found in narrower testing methods.

Understanding Your Immune Markers

• IgM Reactivity: Typically associated with a more recent or active immune response.

• IgG Reactivity: Generally indicates an immune memory or long-term reactivity. ArminLabs calibrates these markers to provide you and your healthcare professional with a clear map of your immune system’s history and current status.

The Science of Antigen Diversity

Borrelia bacteria are known for their ability to shift forms, including "round-body" or pleomorphic states. Because these different forms can trigger different immune responses, our testing includes specific antigens for both active and persistent forms. This multi-antigen approach ensures a more thorough assessment of immune reactivity that standard screenings might overlook.

Regulatory Status: The Tasso+ collection device is FDA-cleared. The laboratory tests provided by ArminLabs are Laboratory Developed Tests (LDTs). These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary for LDTs when performed by a CLIA-certified laboratory.

Educational Use: These results are for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

*This test was developed and its performance characteristics determined by ArminLabs. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is intended for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.